It is typically an immunoglobulin E (IgE)-mediated hypersensitivity reaction (type I), characterized by rapidly developing problems involving the respiratory system (airway, breathing), cardiovascular system (hypotension, tachycardia), and circulation, with associated skin and mucosal changes. This evidence concerns the gene IGHE and hypersensitivity reaction disease.